Your Search Returned 150 tagged news reports
AstraZeneca highlighted progress with a new generation of cancer drugs that may revive its fortunes as it posted a 17 percent fall in core earnings per share on Thursday, reflecting patent losses on profitable older medicines. Britain's second-
has jumped 3.1% to rank among the top large-cap stocks on the day...Pfizer's drive for a deal Pfizer's talks with AstraZeneca about a mammoth merger have been the talk of the health-care sector today, even as talks never moved beyond informal
Pfizer Looking For Another Mega-Merger This Time With AstraZeneca Pfizer Inc. British drug-maker AstraZeneca Group Plc to pull off another mega-merger...The unofficial talks are currently inactive, with both sides decidedly quiet about the news. The
Lynne Cameron/PA New concerns about the security of jobs in the pharmaceutical sector will be raised this week amid speculation that Pfizer of the US has been in takeover talks with its struggling rival the Anglo-Swedish group AstraZeneca .
U.S. pharmaceutical giant Pfizer has approached British rival AstraZeneca to propose a 60 billion pound ($101 billion) takeover, the Sunday Times reported on Sunday. The paper said, citing senior investment bankers and industry sources, that informal
Wall Street sell-off, as Arm leads technology stocks lower Worries about global growth unsettle investors but cement deal lifts CRH A sharp sell-off on Wall Street late last week has spilled over into Asian markets overnight and into early trading in
R Pfizer has announced that the US Food and Drug Administration (FDA) has approved the over-the-counter drug Nexium 24HR (esomeprazole 20mg), which is indicated to treat the symptoms of acid reflux disease, which typically include persistent
Receives Another Breakthrough Therapy Status for a Drug Pfizer Inc. ( PFE ) announced yesterday that the Food and Drug Administration (FDA) had given its investigational vaccine bivalent rLP2086 breakthrough therapy designation. The vaccine is being
AZN The thing about technological and scientific change is that it can happen very quickly. University start-ups can be transformed into global titans think of Facebook . And internationally known giants can end up in the bankruptcy courts think of
February 15, 2014 A 50-year-old man is evaluated for persistent heartburn and regurgitation despite taking a high-dose proton-pump inhibitor twice a day for 6 months. His symptoms have improved, but he continues to have symptoms many times a week...